[ad_1]
More positive news about the fight against the coronavirus pandemic gave Wall Street a boost again on Monday. Positive economic data also ensured a good mood. In addition, various media reports, according to which former Federal Reserve Chief Janet Yellen will be the first woman to assume leadership of the US Treasury, raised hopes for a new economic stimulus program.
Initial earnings of the Dow Jones Industrial
It temporarily melted a bit before the leading US index hit the gas again. At the end of the negotiation, it achieved an increase of 1.12 percent to 29,591.27 points, which more than made up for the setback on Friday. For the S&P 500 of the entire market
Although the corona pandemic is currently raging in the United States, business sentiment brightened significantly in November: The Purchasing Managers Index compiled by research company Markit rose to its highest level in a good five and a half years. . However, analysts had expected a slowdown.
The one from Biontech
According to a government representative, the developed corona vaccine could be available in the US as of December 11 in the event of an emergency approval. The vaccine could be delivered to states within 24 hours of approval by the US FDA, a representative responsible for the US government’s vaccination program told CNN. Biontech’s papers rose 2, 3 percent in New York, while Pfizer shares, which were initially market-friendly, lost just under half a percent.
Curevac New York Listed Stock
rose 6.7 percent after the biotech company with Wacker Chemie
With the British-Swedish pharmaceutical company Astrazeneca
“Even if the overall effectiveness seems a bit lower than with mRNA vaccines, AZD1222 has a huge advantage: it is robust and easy to use, so to speak, the ‘worker bee’ among potentially available Covid-19 vaccines.” the Munich-based company explained. Infectiologist Clemens Wendtner. Axi analyst Stephen Innes called the Astrazeneca news a “big problem.” This would likely allow industrialized countries to immunize most risk groups against lung disease by spring 2021.
Regeneron Stock
At Merck & Co
Aviation stocks visibly benefited from the new Corona news: while American Airlines
despite plans for a new capital increase at a good two and a half percent higher.
At Sensient, shareholders could expect a price increase of nearly two percent. The US company is selling its fragrance division to a German industry colleague Symrise at an unknown price.
The euro
— By Gerold Löhle, dpa-AFX —
ISIN US2605661048 US6311011026 US78378X1072
AXC0373 2020-11-23 / 22: 31
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage is not permitted without the express prior consent of dpa-AFX.
[ad_2]